Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/25/2025

Anemia Diagnosis and Treatment

Diagnosis

  • Anemia is defined as a reduction in hemoglobin concentration, red-cell count, or packed cell volume below normal levels 1
  • Classification by severity:
    • Mild: Hb ≤11.9 g/dl and ≥10 g/dl 1
    • Moderate: Hb ≤9.9 and ≥8.0 g/dl 1
    • Severe: Hb <8.0 g/dl 2
  • Diagnostic workup should include: Peripheral blood smear 1 and assessment for occult blood loss in stool and urine 1

Treatment

  • Oral iron supplementation is first-line therapy: Ferrous sulfate 324 mg (65 mg elemental iron) daily or twice daily, administered between meals to maximize absorption 4
  • Continue iron treatment for 2-3 months after hemoglobin normalization to replenish iron stores 4
  • Parenteral iron therapy is indicated when malabsorption is present 3 or rapid repletion is needed 5
  • Treat the underlying cause: Investigate and address gastrointestinal blood loss in men and postmenopausal women 3
  • Erythropoiesis-stimulating agents (ESAs) may be considered in specific situations: Not recommended for mild to moderate anemia with heart disease 2, 6, 7
  • ESAs may be appropriate for chemotherapy-induced anemia with Hb ≤10 g/dl 1, 8

Special Considerations

  • Transfusion therapy is reserved for severe symptomatic anemia or when rapid correction is needed 2
  • Use restrictive transfusion strategy (Hb trigger 7-8 g/dl) to minimize complications 2, 6, 7
  • Potential complications of transfusions include iron overload, infection transmission, and immune suppression 1
  • Genetic disorders of iron metabolism require specialized treatment approaches, potentially including combination therapy with iron, erythropoietin, and/or transfusions 9

Monitoring and Follow-up

  • For iron deficiency anemia: Repeat hemoglobin measurement after 4 weeks of treatment, and continue treatment for 2 more months after correction 4
  • For other types of anemia: Monitor based on the underlying condition and treatment approach, with regular assessment of iron status and hemoglobin levels 4

Pitfalls and Caveats

  • Failure to identify and treat the underlying cause can lead to recurrence 3
  • ESAs carry risks including hypertension, thromboembolism, and potential tumor progression in cancer patients 1, 2
  • Transfusions should be used judiciously due to associated risks 1, 2